molecules of the month


oral, ultralong-acting insulin analog

effective in Ph. IIa, hum. t1/2~3 d, 4% F dog

albumin-binding motif + reduced endocytosis

J. Med. Chem., Dec. 28, 2020

Novo Nordisk, Maaloev, DK

1 min read

Novo oral insulin analog

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: